Yuhan Pharmaceuticals partners with Cyclica

Drug Discovery |  News | 0 Comment | 13 Nov, 2019

South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology company announce a collaboration to apply Cyclica’s proprietary ...Read more

China approves Alzheimer's drug

Drug Discovery |  News | 0 Comment | 11 Nov, 2019

The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing of the Ganlut sodium capsule (trade name “Nine Phase One”)...Read more

Samsung Biologics collaborates with Ichnos Sciences in derma space

Drug Discovery |  News | 0 Comment | 06 Nov, 2019

South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoc...Read more

EU approves BAVENCIO® (avelumab) Plus Axitinib to treat RCC

Drug Discovery |  News | 0 Comment | 29 Oct, 2019

Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of adu...Read more

Biogen plans regulatory filing for Aducanumab for Alzheimer's

Drug Discovery |  News | 0 Comment | 23 Oct, 2019

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, ...Read more

Takeda acquires license for celiac disease therapy

Drug Discovery |  News | 0 Comment | 22 Oct, 2019

Japanese firm Takeda Pharmaceutical Company  and US based COUR Pharmaceutical Development Company, Inc. have announced that Takeda has acquired an exclusive global license to develop a...Read more

NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

Drug Discovery |  News | 0 Comment | 21 Oct, 2019

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, announced on 17 Oct 2019 that it has commenced dosing of Stelara®...Read more

Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

Drug Discovery |  News | 0 Comment | 18 Oct, 2019

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA...Read more

Lilly's Migraine drug receives FDA approval

Drug Discovery |  News | 0 Comment | 14 Oct, 2019

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of mi...Read more

Gilead Sciences submits NDA to treat RA in Japan

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, selective JAK1 inhibitor for the treatment of adults with rheumatoid arthri...Read more

Bayer and RIKEN establish partnership for novel drug discovery

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreement to jointly explore novel drug discovery opportunities across indic...Read more

Novo Nordisk set to bring innovative treatment for type 2 diabetes

Drug Discovery |  News | 0 Comment | 23 Sep, 2019

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with d...Read more

FDA approves combo drug to treat endometrial carcinoma

Drug Discovery |  News | 0 Comment | 19 Sep, 2019

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the orally available kinase inhibitor discovered by Eisai, plus KEYTRUDA...Read more

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab)

Drug Discovery |  News | 0 Comment | 18 Sep, 2019

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva® (obinutuzumab) f...Read more

FDA grants priority review for Merck’s Ebola Vaccine

Drug Discovery |  Influencers | 0 Comment | 17 Sep, 2019

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted pri...Read more

Certara launches V8.2 of Phoenix PK/PD modeling & simulation software for drugs

Drug Discovery |  News | 0 Comment | 15 Sep, 2019

Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the launch of Phoenix® 8.2, the industry gold standard in pharmacoki...Read more

Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the Congress of European Committee for Treatment and Research in Multipl...Read more

Hansoh Pharma, Atomwise partner for AI Drug Discovery

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificia...Read more